In the minds of some Wall Street investors, Moderna Inc. and Novavax Inc. shares have run their course and are prime candidates for bets that they will fall this year, in a JPMorgan Chase & Co. survey of 80 hedge fund and specialist investors searching for biotech stocks, to short in 2021, the two vaccine […]
